Related Experiment Videos
C1 esterase inhibitor (C1-INH) can reduce plasma concentrations of the complement activation product C5a
Intensive Care Medicine
|January 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Targeting the EWS-FLI1 transcription factor in Ewing sarcoma.
Cancer chemotherapy and pharmacology·2015
Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment.
British journal of cancer·2013
Escalating topotecan in combination with treosulfan has acceptable toxicity in advanced pediatric sarcomas.
Pediatric hematology and oncology·2013
Balancing lung and brain: physiological strategies for ARDS management in acute brain injury.
Intensive care medicine·2026
ARDS management in trauma patients.
Intensive care medicine·2026
State-of-the-art review: ß-blockade in critical illness.
Intensive care medicine·2026
The influence of neuroprotector isatin on haloperidolinduced catalepsy and proteomic profile of mice brain.
Biomeditsinskaia khimiia·2026
Design, Synthesis, and Biological Evaluation of Lipidated Pentapeptide Derivatives Containing Unnatural Amino Acids.
Current protein & peptide science·2026
Research progress on resource distribution, extraction technology, anti-inflammatory mechanisms, and structure-activity relationships of natural anti-inflammatory pectins.
Food research international (Ottawa, Ont.)·2026
Endogenous tracking reveals paralog-specific targets for phosphatidic acid generation during phospholipase C signaling in living cells.
The Journal of biological chemistry·2026
Comparison of predicted C-peptide structures of human and venom insulin G1: A putative γ-glutamyl carboxylase recognition motif in venom insulin.
Toxicon : official journal of the International Society on Toxinology·2026
Possible origin and suppression of apparent +56 Da impurities during peptide synthesis.
Journal of pharmaceutical and biomedical analysis·2026